Search

Search Constraints

You searched for: Author/Creator Kanate, Abraham S.

Search Results

1. Allogeneic haematopoietic cell transplantation for extranodal natural killer/T‐cell lymphoma, nasal type: a CIBMTR analysis. (2nd August 2017)

2. Autologous transplantation versus allogeneic transplantation in patients with follicular lymphoma experiencing early treatment failure. Issue 12 (12th April 2018)

3. Health-related quality-of-life results from the phase 3 OPTIMISMM study: pomalidomide, bortezomib, and low-dose dexamethasone versus bortezomib and low-dose dexamethasone in relapsed or refractory multiple myeloma. Issue 8 (2nd July 2020)

5. Phase 1 Study Evaluating Pharmacokinetics and Tolerability of Ofatumumab Combined With Bendamustine in Patients With Indolent B‐Cell Non‐Hodgkin's Lymphoma. Issue 9 (12th July 2022)

6. Pomalidomide, bortezomib, and dexamethasone at first relapse in lenalidomide‐pretreated myeloma: A subanalysis of OPTIMISMM by clinical characteristics. (22nd September 2021)

7. Predictive factors and outcomes for ibrutinib therapy in relapsed/refractory mantle cell lymphoma—a "real world" study. Issue 4 (8th January 2017)

8. Prospective assessment of Clostridioides (formerly Clostridium) difficile colonization and acquisition in hematopoietic stem cell transplant patients. Issue 6 (16th August 2020)

9. R‐CHOP versus dose‐adjusted R‐EPOCH in frontline management of primary mediastinal B‐cell lymphoma: a multi‐centre analysis. (19th December 2017)